DCOY · Categories · Form 4
DCOY - SEC Form 4 insider transactions
Decoy Therapeutics Inc. (DCOY) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for DCOY
- Director Lieber Jonathan I was granted 2,000 shares, increasing direct ownership by 100,000% to 2,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Business Officer Marschel Peter Klaus was granted 3,900 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Executive Officer Pierce Frederick Ii was granted 33,455 shares, increasing direct ownership by 2,409% to 34,844 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Financial Officer Rosenblum Mark J was granted 9,682 shares, increasing direct ownership by 576% to 11,363 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Chief Scientific Officer Hibner Barbara Louise was granted 4,216 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Hanish Arnold C was granted 3,000 shares, increasing direct ownership by 718% to 3,418 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Lammers Paul was granted 2,000 shares, increasing direct ownership by 200,000% to 2,001 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Burleson Tess was granted 2,000 shares, increasing direct ownership by 100,000% to 2,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Mcvicar William K. was granted 3,000 shares, increasing direct ownership by 150,000% to 3,002 units (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)
- Director Gauthier Patricia G. was granted 2,000 shares (SEC Form 4)4 - Decoy Therapeutics Inc. (0001615219) (Issuer)